Sean Miller

Stock Rating Update on the Shares of Antero Midstream Partners LP (NYSE:AM)

Antero Midstream Partners LP (NYSE:AM) rose 0.30% during previous trade. Wells Fargo issued rating on the stock of Antero Midstream Partners LP (NYSE:AM) in a research note issued to investors on Oct-05-16, the stock received “Upgrade” rating from Market Perform to Outperform. Additionally Tudor Pickering issued their verdict on the stock of the company, on record date of Sep-09-16 the stock was “Upgraded” from Hold to Buy besides that on Sep-07-16 Antero Midstream Partners LP (NYSE:AM) was “Reiterated” by Stifel as Buy from $29 to $31. Furthermore on Jun-16-16 the stock was “Upgraded” by Stifel from Hold to Buy at $19.

Antero Midstream Partners LP (NYSE:AM) shares ended last trading session at the price of $26.70 whereas a number of traders indicating mean target price will hit $33.58 over the next twelve months, mean value of price target most recently revised on 09/30/16. Antero Midstream Partners LP (NYSE:AM)’s highest estimates of price target are $41.00 and low forecast is $27.50 based on the opinion of 13 analysts. The price target estimates represents a standard deviation of 4.00. However brokerage recommendations suggests an ABR of 1.33 based on calls of 12 experts, where 10 brokers polls the stock a Strong Buy, 0 suggest the stock a Buy, 2 suggest Hold, 0 are rating the stock as Sell while 0 as Strong Sell.

Antero Midstream Partners LP (NYSE:AM) is expected to release the earnings of its current quarter on 10/26/16.

Antero Midstream Partners LP (NYSE:AM)’s average revenue estimates for the current quarter are $40.77M according to 4 number of analysts. However its lowest revenue estimates are $31.76M and highest revenue estimates are $40.6M. For the next quarter the company has anticipated average revenues of $52.24M, according to the sentiments of 3 analysts. For the current year the company has fixed $95.75M revenues, as per the opinion of 2 analysts. For the current year the company has low revenue estimates of $80.45M in contradiction of high revenue estimates of $90.33M. Whereas for the next year revenues are set at $387.32M by 7 analysts.

The stock exchanged hands 1,195,400 shares versus average trading capacity of 360,183 shares, while its shares’ total market worth is $4.71B along with 100.24M outstanding shares. Antero Midstream Partners LP (NYSE:AM) shares were trading -6.11% below from the 52-week high price mark of $28.44 and +61.87% above from the 52-week price bottom of $16.49. However the company observed 52 week high price on 07/12/16 and witnessed 52 week low price on 01/20/16. The company’s price sits 1.55% above from its 50-day moving average of $26.70 and 12.94% far from the stock’s 200-day moving average which is $25.27. Antero Midstream Partners LP (NYSE:AM)’s price to sales ratio for trailing twelve month stands at 9.42, whereas its price to book ratio for most recent quarter sits at 4.27. However the company’s price to cash per share for most recent quarter stands at 526.11.

Analyst Sights on Rating and Recommendation: Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) rose 30.36% during previous trade. Piper Jaffray issued rating on the stock of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) in a research note issued to investors on Oct-05-16, the stock received “Upgrade” rating from Neutral to Overweight. Additionally Piper Jaffray issued their verdict on the stock of the company, on record date of Apr-26-16 the stock was “Downgraded” from Overweight to Neutral from $6 to $1 besides that on Sep-30-14 Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) was “Reiterated” by ROTH Capital as Buy from $5 to $6. Furthermore on Sep-16-14 the stock was “Reiterated” by ROTH Capital as Buy from $3.50 to $5.

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) shares ended last trading session at the price of $1.46 whereas a number of traders indicating mean target price will hit $3.63 over the next twelve months, mean value of price target most recently revised on 08/19/16. Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)’s highest estimates of price target are $6.00 and low forecast is $1.00 based on the opinion of 4 analysts. The price target estimates represents a standard deviation of 2.29. However brokerage recommendations suggests an ABR of 1.50 based on calls of 4 experts, where 3 brokers polls the stock a Strong Buy, 0 suggest the stock a Buy, 1 suggest Hold, 0 are rating the stock as Sell while 0 as Strong Sell.

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) is expected to release the earnings of its current quarter on 11/14/16.

The stock exchanged hands 17,403,274 shares versus average trading capacity of 1.02M shares, while its shares’ total market worth is $117.83M along with 82.87M outstanding shares. Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) shares were trading -58.87% below from the 52-week high price mark of $3.55 and +186.27% above from the 52-week price bottom of $0.51. However the company observed 52 week high price on 10/19/15 and witnessed 52 week low price on 04/26/16. The company’s price sits 53.38% above from its 50-day moving average of $1.06 and 27.88% far from the stock’s 200-day moving average which is $0.88. Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)’s price to book ratio for most recent quarter sits at 2.61. However the company’s price to cash per share for most recent quarter stands at 2.61.

Analytical Approach on: First Majestic Silver Corp (NYSE:AG)

First Majestic Silver Corp (NYSE:AG) soared plunged -10.33% during previous trade, a total of 7,600,620 shares exchanged hands compared with its average trading volume of 6.71M shares whereas its relative volume is 1.14. The stock has a market capitalization of $1.63B along with 156.51M outstanding shares. Stock’s intraday price range hit the peak level of $9.53 and touched the lowest level of $8.86.

Most recently First Majestic Silver Corp (NYSE:AG)’s price target was revised on 09/23/16 and according to 6 analysts stock’s price will reach at $16.27 during 52 weeks with standard deviation of 4.98. Stock’s minimum price target estimates has been figured out at $8.79 while the maximum price target forecast is established at $22.17, if we look at the price target with an optimistic approach it has upside potential of 403% from its latest closing price of $8.94.

Historically, if we look at price target revisions, three weeks ago First Majestic Silver Corp (NYSE:AG)’s price target was revised on 08/11/16 by the analysts, however the bullish price estimates of the stock set at $22.04 while the bearish estimates kept at $8.66 over the next one year. Stock’s 52-week target was retained at $16.70, the estimates indicates a standard deviation of 5.13.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 2.86. ABR value is precisely based on brokerage recommendations, where out of 7 brokerage recommendations 1 rate First Majestic Silver Corp (NYSE:AG) stock a Strong Buy, 1 rate the stocks of the company a Buy, 4 rate Hold, 0 rate Sell and 1 recommend a Strong Sell. Most recently on 6/29/2016 the stock of First Majestic Silver Corp (NYSE:AG) downgraded by TD Securities from Buy to Hold. However previously on 5/12/2016 it was upgraded by Desjardins from Sell to Hold. A research note issued on 4/20/2016 the stock was downgraded by Raymond James from Mkt Perform to Underperform.

First Majestic Silver Corp (NYSE:AG) performance over the past one year advanced 148.33% whereas its year to date (YTD) performance indicated a bullish trend of 173.39%. During the last six months the stock rose 39.69%. Quarterly performance of the company shows declining momentum of -41.64% while its last one month trend is negative with -27.73%. Stock’s weekly performance expressed down trend of -14.69%.

The company’s price sits -36.93% below from its 50-day moving average of $12.50 and -6.54% below from the stock’s 200-day moving average which is $12.15. First Majestic Silver Corp (NYSE:AG)’s shares are currently trading -53.32% away from the 52-week high price of $19.15 and +272.50% far from the 52-week low price of $2.40.

According to 1 analysts, First Majestic Silver Corp (NYSE:AG)’s revenue estimates for the current quarter are $60.8M meanwhile the company has high revenue estimates of $66M in contradiction of low revenue estimates of $66M. For the current year the company’s revenue estimates are $245.5M compared to low analyst estimates of $251M and high estimates of $251M according to the projection of 1 analysts.

Analyst Views on Price Target: Whiting Petroleum Corp (NYSE:WLL)

Whiting Petroleum Corp (NYSE:WLL) plunged -4.83% during previous trade, a total of 21,610,300 shares exchanged hands compared with its average trading volume of 26.11M shares whereas its relative volume is 0.83. The stock has a market capitalization of $2.38B along with 275.40M outstanding shares. Stock’s intraday price range hit the peak level of $9.00 and touched the lowest level of $8.41.

Most recently Whiting Petroleum Corp (NYSE:WLL)’s price target was revised on 10/03/16 and according to 33 analysts stock’s price will reach at $11.55 during 52 weeks with standard deviation of 3.62. Stock’s minimum price target estimates has been figured out at $4.60 while the maximum price target forecast is established at $20.00, if we look at the price target with an optimistic approach it has upside potential of 136% from its latest closing price of $8.48.

Historically, if we look at price target revisions, two weeks ago Whiting Petroleum Corp (NYSE:WLL)’s price target was revised on 09/13/16 by the analysts, however the bullish price estimates of the stock set at $19.00 while the bearish estimates kept at $7.00 over the next one year. Stock’s 52-week target was retained at $12.28, the estimates indicates a standard deviation of 3.64.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 2.24. ABR value is precisely based on brokerage recommendations, where out of 21 brokerage recommendations 7 rate Whiting Petroleum Corp (NYSE:WLL) stock a Strong Buy, 2 rate the stocks of the company a Buy, 12 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 7/13/2016 the stock of Whiting Petroleum Corp (NYSE:WLL) upgraded by Credit Suisse from Neutral to Outperform. However previously on 7/12/2016 it was upgraded by Seaport Global Securities from Sell to Neutral. A research note issued on 7/6/2016 the stock was downgraded by Goldman from Buy to Neutral.

Whiting Petroleum Corp (NYSE:WLL) performance over the past one year plunged -55.08% whereas its year to date (YTD) performance indicated a bearish trend of -10.17%. During the last six months the stock slipped -1.85%. Quarterly performance of the company shows optimistic momentum of 0.47% while its last one month trend is positive with 14.59%. Stock’s weekly performance expressed up trend of 17.29%.

The company’s price sits 11.22% above from its 50-day moving average of $7.72 and -0.65% below from the stock’s 200-day moving average which is $9.31. Whiting Petroleum Corp (NYSE:WLL)’s shares are currently trading -62.81% away from the 52-week high price of $22.80 and +153.13% far from the 52-week low price of $3.35.

According to 4 analysts, Whiting Petroleum Corp (NYSE:WLL)’s revenue estimates for the current quarter are $159.92M meanwhile the company has high revenue estimates of $169.18M in contradiction of low revenue estimates of $152.15M. For the current year the company’s revenue estimates are $818.72M compared to low analyst estimates of $778.6M and high estimates of $816.02M according to the projection of 8 analysts.

Analyst’s Reviews on Rating under Consideration: Rowan Companies PLC (NYSE:RDC)

Rowan Companies PLC (NYSE:RDC) fell -2.84% during previous trade. Societe Generale issued rating on the stock of Rowan Companies PLC (NYSE:RDC) in a research note issued to investors on Oct-03-16, the stock received “Downgraded” rating from Hold to Sell. Additionally Credit Suisse issued their verdict on the stock of the company, on record date of Sep-23-16 the stock was “Downgraded” from Outperform to Neutral besides that on Sep-14-16 Rowan Companies PLC (NYSE:RDC) was “Resumed” by Scotia Howard Weil as Sector Perform. Furthermore on Aug-12-16 the stock was “Reiterated” by RBC Capital Mkts as Sector Perform from $22 to $16.

Rowan Companies PLC (NYSE:RDC) shares ended last trading session at the price of $14.73 whereas a number of traders indicating mean target price will hit $15.13 over the next twelve months, mean value of price target most recently revised on 10/03/16. Rowan Companies PLC (NYSE:RDC)’s highest estimates of price target are $25.00 and low forecast is $10.00 based on the opinion of 31 analysts. The price target estimates represents a standard deviation of 3.73. However brokerage recommendations suggests an ABR of 2.68 based on calls of 19 experts, where 4 brokers polls the stock a Strong Buy, 0 suggest the stock a Buy, 13 suggest Hold, 2 are rating the stock as Sell while 0 as Strong Sell.

Rowan Companies PLC (NYSE:RDC) is expected to release the earnings of its current quarter on 11/1/16.

Rowan Companies PLC (NYSE:RDC)’s average revenue estimates for the current quarter are $462.3M according to 15 number of analysts. However its lowest revenue estimates are $411.2M and highest revenue estimates are $442.9M. A year ago the company’s sales were $299.79M. Its yearly sales growth estimates are 54.20%. For the next quarter the company has anticipated average revenues of $507M, according to the sentiments of 15 analysts. For the current year the company has fixed $2.1B revenues, as per the opinion of 18 analysts. For the current year the company has low revenue estimates of $1.97B in contradiction of high revenue estimates of $2.05B. Whereas for the next year revenues are set at $2.21B by 19 analysts.

The stock exchanged hands 4,826,000 shares versus average trading capacity of 3.78M shares, while its shares’ total market worth is $1.85B along with 125.42M outstanding shares. Rowan Companies PLC (NYSE:RDC) shares were trading -32.20% below from the 52-week high price mark of $21.73 and +38.05% above from the 52-week price bottom of $10.67. However the company observed 52 week high price on 11/03/15 and witnessed 52 week low price on 02/11/16. The company’s price sits 6.61% above from its 50-day moving average of $13.43 and -4.43% away from the stock’s 200-day moving average which is $15.95. Rowan Companies PLC (NYSE:RDC)’s price to sales ratio for trailing twelve month stands at 0.84, whereas its price to book ratio for most recent quarter sits at 0.36. However the company’s price to cash per share for most recent quarter stands at 2.43. Its price to free cash flow for trailing twelve months is 2.50.

Stock Overselling in Action: Novo Nordisk A/S (ADR) (NYSE:NVO)

Novo Nordisk A/S (ADR) (NYSE:NVO) share price plunged -1.13% or -0.47 points to reach at $41.12 during previous trading session. The stock’s price fluctuated within the range of $40.83 – $41.15 during previous trading session. A total of 3.58M shares exchanged hands, whereas the company’s average trading volume stands at 2.95M shares. Novo Nordisk A/S (ADR) (NYSE:NVO) has a market capitalization of $82.13B and most recently 1.96B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Novo Nordisk A/S (ADR) (NYSE:NVO) is at 18.93.

According to sentiments of 1 analysts the mean estimates of short term price target for the company’s stock is marked at $57.00. The most optimistic analyst sees the stock reaching $57.00 while the most conventional predicts the target price at $57.00.

The consensus mean EPS for the current quarter is at $0.58 derived from a total of 1 estimates. According to analysts minimum EPS for the current quarter is expected at $0.58 and can go high up to $0.58. However a year ago during same quarter Novo Nordisk A/S (ADR) (NYSE:NVO) reported $0.49 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.56 per share according to consensus of 1 analysts.

According to sentiments of 1 analysts the company is expected to report revenues of $4.25B for the current quarter. Bearish revenue estimates established at $4.25B while the bullish revenue forecast has been figured out at $4.25B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 3.00 on the shares of Novo Nordisk A/S (ADR) (NYSE:NVO). Out of rating recommendations 0 have given the stock a Buy while 0 recommend the stock as Outperform. 1 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Novo Nordisk A/S (ADR) (NYSE:NVO)’s distance from 20 day simple moving average is -8.81% whereas its distance from 50 day simple moving average is -14.26% along with -21.24% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Novo Nordisk A/S (ADR) (NYSE:NVO) hit its 52-week high price on 12/30/15, and 52-week low price on 10/03/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -7.45% in the past one week and plunged -11.26% during previous one month drive, the stock went down -23.45% during past quarter. In the last six months the stock’s performance fell -24.78% while yearly performance of the company fell -23.14%. The company’s year to date (YTD) performance is at -27.26%.

While taking a glance at financials, we can look at a number of key indicators. Novo Nordisk A/S (ADR) (NYSE:NVO) has a Return on Assets (ROA) of 41.50%. The company currently has a Return on Equity (ROE) of 84.90% and a Return on Investment (ROI) of 85.00%. Average true range (ATR-14) of the company sets at 0.83, along with its weekly and monthly volatility of 1.45%, 1.41% respectively. Beta value of the stock stands at 0.73.

The company’s price to free cash flow for trailing twelve months is 27.04. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.30. Total debt to equity ratio of the company for most recent quarter is 0.01 whereas long term debt to equity ratio for most recent quarter is 0.00.

Analysts See Compelling Value in Jones Energy Inc (NYSE:JONE)

Jones Energy Inc (NYSE:JONE) soared 5.64% during previous trade, a total of 4,763,900 shares exchanged hands compared with its average trading volume of 1.33M shares whereas its relative volume is 3.84. The stock has a market capitalization of $314.74M along with 53.82M outstanding shares. Stock’s intraday price range hit the peak level of $3.28 and touched the lowest level of $3.745.

Most recently Jones Energy Inc (NYSE:JONE)’s price target was revised on 09/21/16 and according to 7 analysts stock’s price will reach at $5.25 during 52 weeks with standard deviation of 2.72. Stock’s minimum price target estimates has been figured out at $2.50 while the maximum price target forecast is established at $10.00, if we look at the price target with an optimistic approach it has upside potential of 181% from its latest closing price of $3.56.

Historically, if we look at price target revisions, three weeks ago Jones Energy Inc (NYSE:JONE)’s price target was revised on 08/30/16 by the analysts, however the bullish price estimates of the stock set at $10.00 while the bearish estimates kept at $2.50 over the next one year. Stock’s 52-week target was retained at $4.79, the estimates indicates a standard deviation of 2.68.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 2.56. ABR value is precisely based on brokerage recommendations, where out of 9 brokerage recommendations 2 rate Jones Energy Inc (NYSE:JONE) stock a Strong Buy, 2 rate the stocks of the company a Buy, 4 rate Hold, 0 rate Sell and 1 recommend a Strong Sell. Most recently on 8/10/2016 the stock of Jones Energy Inc (NYSE:JONE) downgraded by Barclays from Equal Weight to Underweight. However previously on 5/24/2016 it was upgraded by Iberia from Sector Perform to Outperform. A research note issued on 4/27/2016 the stock was upgraded by Imperial Capital from In-line to Outperform.

Jones Energy Inc (NYSE:JONE) performance over the past one year plunged -23.28% whereas its year to date (YTD) performance indicated a bearish trend of -7.53%. During the last six months the stock rose 16.72%. Quarterly performance of the company shows declining momentum of -16.43% while its last one month trend is positive with 28.52%. Stock’s weekly performance expressed up trend of 20.68%.

The company’s price sits 12.46% above from its 50-day moving average of $2.98 and 6.49% far from the stock’s 200-day moving average which is $3.72. Jones Energy Inc (NYSE:JONE)’s shares are currently trading -41.16% away from the 52-week high price of $6.05 and +206.90% far from the 52-week low price of $1.16.

According to consensus agreement of 11 analysts Jones Energy Inc (NYSE:JONE) will report earnings per share of $-0.12 in their quarterly report and it is expected to announce the company’s results on 11/2/16. For the current quarter the company has high EPS estimates of $-0.01 in contradiction of low EPS estimates of $-0.5. However a year ago for the same quarter the company has reported $-0.03 EPS. Current year EPS projections for Jones Energy Inc (NYSE:JONE) are set at $-0.24 according to the sentiments of 6 analysts, while its lowest earnings estimates are $-0.47 and highest earnings estimates are $-0.14.

According to 9 analysts, Jones Energy Inc (NYSE:JONE)’s revenue estimates for the current quarter are $44.67M meanwhile the company has high revenue estimates of $63M in contradiction of low revenue estimates of $28.45M. For the current year the company’s revenue estimates are $165.34M compared to low analyst estimates of $119M and high estimates of $256.96M according to the projection of 9 analysts.

Steady Stocks: Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), Cisco Systems, Inc. (NASDAQ:CSCO)

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) share price went up 14.02% or +0.37 points to reach at $3.01 during the course of previous trade. The stock traded in the range of $2.93 – $3.72 during its most recent trading session. The stock has total market worth of $106.22M and it has total of 35.29M outstanding shares. Relative strength index (RSI-14) for Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is at 70.19.

Historically the stock has climbed 25.42% in the past week and soared 55.15% in the last four weeks, the stock illustrate that its three months performance stands at 0.33% while its year to date performance is at 21.86%. Stock’s price oscillated from $1.42 to $4.49 during past twelve months. The stock is now trading at a distance of 37.75% from SMA-20. The stock is presently trading 15.98% above from its SMA-50. In the current trading session, the stock’s price moved 15.47% above from its SMA-200. If we take a look on its volatility, 10.07 percent was seen in a week and for the month it was 6.38 percent. Stock’s ATR value is at 0.19.

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) a clinical stage biopharmaceutical company focused on the global immunology market, on September 30, 2016 announced that in addition to voclosporin (23.7 mg BID) achieving its primary endpoint of Complete Remission (CR) at 24 weeks, both doses of voclosporin when added to the current standard of care of Mycophenolate Mofetil (MMF) and a forced oral corticosteroid taper have met all 24-week pre-specified secondary endpoints vs the control group. These pre-specified endpoints include: Partial Remission (PR), which is measured by a ≥50% reduction in UPCR with no concomitant use of rescue medication; time to CR and PR; reduction in Systemic Lupus Erythematosus Disease Activity Index or SLEDAI score; and reduction in UPCR over the 24-week treatment period.

Cisco Systems, Inc. (NASDAQ:CSCO) share price rose 1.05% or +0.33 points to reach at $31.72 during previous trading session. Stock’s price oscillated between $31.56 and $31.80 for intra-day trading. Relative strength index (RSI-14) for Cisco Systems, Inc. (NASDAQ:CSCO) is at 57.21. It has total market capitalization of $160.73B.

Historically the stock has climbed 1.21% in the past week and soared 0.89% in the last four weeks, the stock illustrate that its three months performance stands at 11.14% while its year to date performance is at 19.86%. The stock hit the peak price level of one year at $31.95 and touched the minimum level of $22.06. Shares are trading -0.72% off from the 52-week high price and +43.82% above from the 52-week bottom price level. The stock is now trading at a distance of 1.19% from SMA-20. The stock is presently trading 2.05% above from its SMA-50. In the current trading session, the stock’s price moved 13.80% above from its SMA-200. The company has a Return on Assets of 9.20%. The company currently has a Return on Equity of 17.40% and a Return on Investment of 11.40%.

Celestica Inc. (CLS), a global leader in the delivery of end-to-end product lifecycle solutions, on September 26, 2016 announced that it has received the 2016 Excellence in Sustainability award from Cisco Systems, Inc. (NASDAQ:CSCO).

This prestigious award recognizes Celestica for Excellence in Sustainability for demonstrating sustainability leadership above and beyond standard sustainability practices, and leading the industry through its approaches to reduce negative environmental impacts and raise positive social impacts. The distinction was awarded during Cisco’s 25th Annual Supplier Appreciation Event, held September 8 at the Santa Clara Convention Center in California.

Cisco presented awards to suppliers in recognition of their contributions to Cisco’s success in fiscal year 2016. Celebrating 25 years of partnering, Cisco recognized the dedication and successes of the very best of its strategic suppliers and manufacturing partners — critical to a complex, global supply chain like Cisco.

Price Target Estimates Under Analyst’s Radar: IAMGOLD Corp (USA) (NYSE:IAG)

IAMGOLD Corp (USA) (NYSE:IAG) plunged -3.80% during previous trade, a total of 10.76M shares exchanged hands compared with its average trading volume of 13.01M shares whereas its relative volume is 0.85. The stock has a market capitalization of $1.72B along with 450.66M outstanding shares. Stock’s intraday price range hit the peak level of $4.31 and touched the lowest level of $4.03.

Most recently IAMGOLD Corp (USA) (NYSE:IAG)’s price target was revised on 09/23/16 and according to 13 analysts stock’s price will reach at $5.67 during 52 weeks with standard deviation of 1.89. Stock’s minimum price target estimates has been figured out at $3.80 while the maximum price target forecast is established at $7.65, if we look at the price target with an optimistic approach it has upside potential of 91% from its latest closing price of $4.05.

Historically, if we look at price target revisions, one week ago IAMGOLD Corp (USA) (NYSE:IAG)’s price target was revised on 09/12/16 by the analysts, however the bullish price estimates of the stock set at $6.55 while the bearish estimates kept at $1.75 over the next one year. Stock’s 52-week target was retained at $5.01, the estimates indicates a standard deviation of 1.89.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 3.00. ABR value is precisely based on brokerage recommendations, where out of 5 brokerage recommendations 0 rate IAMGOLD Corp (USA) (NYSE:IAG) stock a Strong Buy, 1 rate the stocks of the company a Buy, 3 rate Hold, 1 rate Sell and 0 recommend a Strong Sell. Most recently on 8/8/2016 the stock of IAMGOLD Corp (USA) (NYSE:IAG) upgraded by RBC Capital Mkts from Underperform to Sector Perform. However previously on 6/30/2016 it was upgraded by                 Credit Suisse from Underperform to Neutral. A research note issued on 6/27/2016 the stock was upgraded by CIBC from Sector Underperform to Sector Perform.

IAMGOLD Corp (USA) (NYSE:IAG) performance over the past one year advanced 161.29% whereas its year to date (YTD) performance indicated a bullish trend of 185.21%. During the last six months the stock rose 86.64%. Quarterly performance of the company shows declining momentum of -9.40% while its last one month trend is positive with 9.46%. Stock’s weekly performance expressed down trend of -1.70%.

The company’s price sits -10.59% below from its 50-day moving average of $4.25 and 26.29% far from the stock’s 200-day moving average which is $3.83. IAMGOLD Corp (USA) (NYSE:IAG)’s shares are currently trading -31.01% away from the 52-week high price of $5.87 and +252.17% far from the 52-week low price of $1.15.

According to consensus agreement of 11 analysts IAMGOLD Corp (USA) (NYSE:IAG) will report earnings per share of $0.02 in their quarterly report and it is expected to announce the company’s results on 11/1/16. For the current quarter the company has high EPS estimates of $0.05 in contradiction of low EPS estimates of $-0.04. However a year ago for the same quarter the company has reported $-0.12 EPS. Current year EPS projections for IAMGOLD Corp (USA) (NYSE:IAG) are set at $0.04 according to the sentiments of 13 analysts, while its lowest earnings estimates are $-0.12 and highest earnings estimates are $0.12.

According to 3 analysts, IAMGOLD Corp (USA) (NYSE:IAG)’s revenue estimates for the current quarter are $269.93M meanwhile the company has high revenue estimates of $284.58M in contradiction of low revenue estimates of $261.96M. For the current year the company’s revenue estimates are $990.98M compared to low analyst estimates of $931M and high estimates of $1.03B according to the projection of 13 analysts.

Analyst’s Review to Watch: Noble Corporation Ordinary Shares (UK) (NYSE:NE)

Noble Corporation Ordinary Shares (UK) (NYSE:NE) soared 0.63% during previous trade, a total of 11.32M shares exchanged hands compared with its average trading volume of 10.43M shares whereas its relative volume is 1.18. The stock has a market capitalization of $1.53B along with 243.22M outstanding shares. Stock’s intraday price range hit the peak level of $6.45 and touched the lowest level of $6.19.

Most recently Noble Corporation Ordinary Shares (UK) (NYSE:NE)’s price target was revised on 09/28/16 and according to 30 analysts stock’s price will reach at $6.94 during 52 weeks with standard deviation of 2.00. Stock’s minimum price target estimates has been figured out at $3.60 while the maximum price target forecast is established at $10.00, if we look at the price target with an optimistic approach it has upside potential of 58% from its latest closing price of $6.34.

Historically, if we look at price target revisions, one week ago Noble Corporation Ordinary Shares (UK) (NYSE:NE)’s price target was revised on 09/21/16 by the analysts, however the bullish price estimates of the stock set at $11.00 while the bearish estimates kept at $3.60 over the next one year. Stock’s 52-week target was retained at $7.60, the estimates indicates a standard deviation of 1.95.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 3.23. ABR value is precisely based on brokerage recommendations, where out of 20 brokerage recommendations 1 rate Noble Corporation Ordinary Shares (UK) (NYSE:NE) stock a Strong Buy, 1 rate the stocks of the company a Buy, 13 rate Hold, 2 rate Sell and 3 recommend a Strong Sell. Most recently on 9/21/2016 the stock of Noble Corporation Ordinary Shares (UK) (NYSE:NE) upgraded by Goldman from Sell to Neutral. However previously on 8/16/2016 it was upgraded by BofA/Merrill from Underperform to Neutral. A research note issued on 4/11/2016 the stock was downgraded by Societe Generale from Buy to Hold.

Noble Corporation Ordinary Shares (UK) (NYSE:NE) performance over the past one year plunged -38.03% whereas its year to date (YTD) performance indicated a bearish trend of -38.42%. During the last six months the stock slipped -33.81%. Quarterly performance of the company shows declining momentum of -28.89% while its last one month trend is positive with 10.07%. Stock’s weekly performance expressed up trend of 16.97%.

The company’s price sits 0.41% above from its 50-day moving average of $5.89 and -25.92% below from the stock’s 200-day moving average which is $8.37. Noble Corporation Ordinary Shares (UK) (NYSE:NE)’s shares are currently trading -55.62% away from the 52-week high price of $14.29 and +24.56% far from the 52-week low price of $5.09.

According to consensus agreement of 36 analysts Noble Corporation Ordinary Shares (UK) (NYSE:NE) will report earnings per share of $-0.18 in their quarterly report and it is expected to announce the company’s results on 10/26/16. For the current quarter the company has high EPS estimates of $0.01 in contradiction of low EPS estimates of $-0.3. However a year ago for the same quarter the company has reported $0.72 EPS. Current year EPS projections for Noble Corporation Ordinary Shares (UK) (NYSE:NE) are set at $-0.06 according to the sentiments of 30 analysts, while its lowest earnings estimates are $-0.3 and highest earnings estimates are $0.2.

According to 27 analysts, Noble Corporation Ordinary Shares (UK) (NYSE:NE)’s revenue estimates for the current quarter are $413.81M meanwhile the company has high revenue estimates of $462M in contradiction of low revenue estimates of $381.26M. For the current year the company’s revenue estimates are $2.03B compared to low analyst estimates of $1.92B and high estimates of $2.37B according to the projection of 22 analysts.